Acyclovir
- Product NDC
- 68999-803
- 11-digit product format
- 689990803
- Labeler code
- 68999
- Product ID
- 68999-803_46a3a089-45f8-184c-e063-6294a90a9bc4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Chartwell Governmental & Specialty RX, LLC.
- Application
- ANDA212718
- Marketing category
- ANDA
- Marketing start
- 2020-04-23
- Substance
- ACYCLOVIR
- Active strength
- 200 mg/5mL
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acyclovir
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACYCLOVIR | 200 mg/5mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | X4HES1O11F |
| Rxcui | 307730 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33190c02-82e1-0a4d-d716-9ccd23588463 | Product name | 5 | 20250225 |
| c367d1da-5a72-8966-6d11-1eb9a73ae758 | Product name | 3 | 20231115 |
| 5518bf13-db2f-2e9c-3679-e70ecf03752c | Product name | 9 | 20210614 |
| 27897900-0e40-497b-97e1-88057e68fe6c | Product name | 4 | 20200710 |
| ca834e59-e669-229c-9288-0ccb76dc373e | Product name | 9 | 20200220 |
| d7f95c49-d3e1-4bbc-a389-e9cd73f59a28 | Product name | 1 | 20190702 |
| fb15b394-3715-4c87-a447-421489aa8739 | Product name | 3 | 20170727 |
| 7bdc4804-3832-c0df-e519-72b6d47c9792 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68999-803-05 | Acyclovir | 5 mL in 1 CUP | SUSPENSION | 5 | 1 | |
| 68999-803-20 | Acyclovir | 20 mL in 1 CUP | SUSPENSION | 20 | 1 | |
| 68999-803-23 | Acyclovir | 10 in 1 TRAY | SUSPENSION | 10 | 1 | |
| 68999-803-23 | Acyclovir | 2 in 1 BOX | SUSPENSION | 2 | 1 | |
| 68999-803-24 | Acyclovir | 10 in 1 TRAY | SUSPENSION | 10 | 1 | |
| 68999-803-24 | Acyclovir | 2 in 1 BOX | SUSPENSION | 2 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68999-803-05 | ML - Milliliter | 68999-803 | 271b8197-8986-496b-94d1-d1ae4d55f7f0 | 1 | 2026-03-17 |
| 68999-803-20 | ML - Milliliter | 68999-803 | ef914da3-9819-4c70-8dc5-4fd2bf99caed | 1 | 2026-03-17 |
| 68999-803-23 | ML - Milliliter | 68999-803 | eb160a02-2ca1-4529-96e7-e23af5e36cc4 | 1 | 2026-03-17 |
| 68999-803-24 | ML - Milliliter | 68999-803 | 4602e8cc-7e17-4e4b-b24f-c95396d1dfd1 | 1 | 2026-03-17 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 307730 | acyclovir 200 MG in 5 mL Oral Suspension | PSN | 2757bb30-3374-4e1b-b496-14874f7ec623 | 1 |
| 307730 | acyclovir 40 MG/ML Oral Suspension | SCD | 2757bb30-3374-4e1b-b496-14874f7ec623 | 1 |
| 307730 | acyclovir 200 MG per 5 ML Oral Suspension | SY | 2757bb30-3374-4e1b-b496-14874f7ec623 | 1 |
| 307730 | acycycloguanosine 40 MG/ML Oral Suspension | SY | 2757bb30-3374-4e1b-b496-14874f7ec623 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68999-803-05 | 68999080305 | 5 mL in 1 CUP | 5 ml | Historical | |||
| 68999-803-20 | 68999080320 | 20 mL in 1 CUP | 20 ml | Historical | |||
| 68999-803-23 | 68999080323 | 2 TRAY in 1 BOX (68999-803-23) / 10 CUP in 1 TRAY / 20 mL in 1 CUP (68999-803-20) | 2 tray | 2025-12-19 | No | No | Historical |
| 68999-803-24 | 68999080324 | 2 TRAY in 1 BOX (68999-803-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-803-05) | 2 tray | 2025-12-19 | No | No | Historical |